Gaudium IVF IPO Day 2: Check GMP trend, subscription status, broker views and key details

Gaudium IVF and Women Health IPO entered Day 2 with an 11% GMP and 88% subscription on Day 1, driven by retail demand. Brokerages recommend subscribing, citing strong growth and margins, though valuations remain premium. The issue reflects rising investor interest in India’s expanding fertility services sector.